Pre-order Enquiry
Request Free Sample
2020-2025 Global Drugs For Antifolate Compounds Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
SKU ID : Maia-17107283 | Publishing Date : 07-Jan-2021 | No. of pages : 129
Request Sample
Request Customization
Check Discounts
Antifolates are a class of antimetabolite medications that antagonise (that is, block) the actions of folic acid (vitamin B9).[1] Folic acid's primary function in the body is as a cofactor to various methyltransferases involved in serine, methionine, thymidine and purine biosynthesis. Consequently, antifolates inhibit cell division, DNA/RNA synthesis and repair and protein synthesis. Some such as proguanil, pyrimethamine and trimethoprim selectively inhibit folate's actions in microbial organisms such as bacteria, protozoa and fungi. The majority of antifolates work by inhibiting dihydrofolate reductase (DHFR).
This report elaborates the market size, market characteristics, and market growth of the Drugs For Antifolate Compounds industry, and breaks down according to the type, application, and consumption area of Drugs For Antifolate Compounds. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Drugs For Antifolate Compounds in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Drugs For Antifolate Compounds market covered in Chapter 13:
Cipla
IPCA Laboratories
Alimta
Bristol-Myers
GlaxoSmithKline
IPCA Laboratories
Eli Lilly
Genentech
Kissei Pharmaceutical
Mylan Labs
Baoding Zhongbao Chemical
In Chapter 6, on the basis of types, the Drugs For Antifolate Compounds market from 2015 to 2025 is primarily split into:
Antineoplastic & immunosuppressant
Antineoplastic
Antimalarial
Antiprotozoal
Broad-spectrum antimicrobial
In Chapter 7, on the basis of applications, the Drugs For Antifolate Compounds market from 2015 to 2025 covers:
Methotrexate
Pemetrexed
Proguanil
Pyrimethamine
Trimethoprim
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
2019
This report elaborates the market size, market characteristics, and market growth of the Drugs For Antifolate Compounds industry, and breaks down according to the type, application, and consumption area of Drugs For Antifolate Compounds. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Drugs For Antifolate Compounds in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Drugs For Antifolate Compounds market covered in Chapter 13:
Cipla
IPCA Laboratories
Alimta
Bristol-Myers
GlaxoSmithKline
IPCA Laboratories
Eli Lilly
Genentech
Kissei Pharmaceutical
Mylan Labs
Baoding Zhongbao Chemical
In Chapter 6, on the basis of types, the Drugs For Antifolate Compounds market from 2015 to 2025 is primarily split into:
Antineoplastic & immunosuppressant
Antineoplastic
Antimalarial
Antiprotozoal
Broad-spectrum antimicrobial
In Chapter 7, on the basis of applications, the Drugs For Antifolate Compounds market from 2015 to 2025 covers:
Methotrexate
Pemetrexed
Proguanil
Pyrimethamine
Trimethoprim
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
